Financial Shenanigans

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Financial Shenanigans — Eicher Motors Limited

1. The Forensic Verdict

Eicher's reported numbers look like a faithful representation of the business — the forensic risk score is 22 / 100 (Watch), not "Clean," because the income statement is becoming materially more dependent on treasury yield and the working-capital pattern has flipped from negative to positive over five years. Cash conversion is solid (3-year CFO / Net Income of 0.90, FCF / Net Income of 0.69), the balance sheet is essentially debt-free ($54M borrowings against $1,731M of investments), the statutory auditor's report is unqualified, and no restatement, regulatory accounting action, or short-seller report exists. The two yellow flags worth underwriting are (a) other income (treasury yield on the $1,731M investment book) is now 42% of operating profit — up from 19% in FY18 and (b) working-capital days have moved from −64 in FY18 to +31 in FY25 as receivables and inventory days drift higher. The one data point that would change the grade is the next two quarters of CFO / Net Income — a drop to under 0.7 alongside another step-up in receivables would push the score into Elevated.

2. Breeding Ground

The governance set-up is founder-led but transparent, and the auditor framework is conventional — neither materially raises nor reduces accounting risk. Siddhartha Lal stepped down as MD effective 1 August 2024 after a long tenure, with Vinod Aggarwal (VECV CEO since 2009) taking over as MD & CEO of Eicher Motors and B. Govindarajan becoming CEO of Royal Enfield. The Lal family promoter group has held a remarkably stable 49.06–49.18% stake across the last 12 quarterly disclosures, with no buy or sell program. Foreign institutional ownership has drifted from 30.3% to 26.8% over two years while domestic institutional ownership rose from 10.0% to 14.7% — a rotation, not a sponsorship loss.

The breeding-ground signal is neutral: a 49%-held promoter company with a long-tenured CFO is not unusual in India and the FY25 MD&A includes the standard internal-controls language signed off by the statutory auditor. The only item the available files cannot confirm is the structure of executive incentive comp (the proxy summary is text-only; compensation.json is empty of figures), and that is the one disclosure to read before sizing.

3. Earnings Quality

The income statement is broadly faithful to the cash mechanics, but the share of pre-tax profit coming from treasury other income has risen meaningfully — that is the single earnings-quality observation that matters here. Operating margin moved 21% → 24% → 26% → 25% across FY22–FY25; other income, however, climbed from $66M in FY22 to $233M in FY25 (CAGR 52% in USD), and its share of operating profit doubled from 22.8% to 42.2%. This is legitimately earned yield on a $1,731M investment book — not phantom income — but it is rate-sensitive and largely outside the operating moat.

The receivables test produces a small yellow flag: implied receivables (debtor days × revenue) jumped from ~$44M in FY24 to ~$67M in FY25 (+57%) while revenue rose 14% — a 43 percentage-point gap. This is partly mechanical (DSO moved from 8 to 11 days, still very low by industrial standards) and partly the natural consequence of growing international and spares/accessories sales. It is worth tracking but does not by itself imply revenue pull-forward.

The capitalisation tests are clean. Capex / depreciation has averaged 1.3–1.4x in the last four years (FY22 1.41x, FY23 1.28x, FY24 1.36x, FY25 1.41x), consistent with stated EV-platform and Cheyyar capacity build-out; CWIP is $57M in FY25, down from $67M in FY24. There is no callout of capitalised software, capitalised customer-acquisition costs, or capitalised contract costs in the AR — the cost stack is conventional manufacturing opex. No restructuring charges or impairments have been disclosed in the eight-year window — a positive signal that management is not using "one-time" items to manage the income statement, but also a reminder that the next genuine model write-down (e.g. an EV launch that misses) will hit straight to P&L.

4. Cash Flow Quality

Cash conversion is good but not pristine, and it is gradually deteriorating because working capital is now a use of cash rather than a source. Across FY23–FY25 the company generated $1,255M of operating cash flow against $1,388M of net income — a 3-year ratio of 0.90, with FCF of $955M (FCF/NI of 0.69 after $300M of cumulative capex). That is healthy but no longer in the 1.1× CFO/NI band the company posted FY18–FY21. The gap is explained by the working-capital flip, not by suspicious classification.

The working-capital story is the clearest yellow flag. In FY18 the company ran on a structurally negative working-capital cycle (−64 days) — cash from customers and supplier credit funded inventory. By FY25 that cycle has flipped to +31 days as inventory days expanded (31 → 55) and DSO crept up (3 → 11). The number is still excellent in absolute terms (most industrial OEMs sit at 60–90+ days), but the trend has consumed cash:

The mechanics behind the CFO/NI gap are mundane: the FY25 cash flow statement shows CFO of $466M against operating profit of $553M (CFO/OP "ratio" of 107% per the Screener computation), with the gap between net income ($554M) and CFO ($466M) of $88M explained primarily by non-cash other income — the $233M of treasury yield includes mark-to-market and accrual items that hit P&L before showing up as investing-line proceeds. There is no factoring program, no supplier-finance arrangement, no securitisation disclosed; CFFO is not being propped up by financing-style mechanisms. The Capex-line activity (FY25 $120M) and the much larger Investing-line outflow ($288M net) are dominated by treasury redeployment, not by capitalised opex masquerading as investing.

5. Metric Hygiene

Eicher's metric hygiene is quite good — there is no "adjusted EBITDA" with surprise add-backs, no renamed KPIs across years, and the headline figures in the FY25 MD&A reconcile to the consolidated statements. The one nuance that matters for forensic interpretation is the equity-method treatment of VECV: the 54.4%-owned commercial-vehicle JV is reported as a single line (Share of Profit of JV — $82M in FY25, +56% YoY) and its revenue and EBITDA are explicitly excluded from the consolidated top line. This is correct under IndAS 28, but it means the headline "$2,208M revenue" and "EBITDA margin 25.0%" understate the group's true economic activity. Management is transparent about this in the AR; the risk is purely interpretive, not hygienic.

There is one disclosure the AR itself flags as required reading: Net Capital Turnover Ratio collapsed from 29.9× in FY24 to 7.0× in FY25 on the consolidated view (the AR explicitly cites the >25% change rule under SEBI LODR and points readers to Note 54 / Note 55). This is the working-capital flip described above in arithmetic form — the average working capital expanded sharply, dropping turnover. It is disclosed; it is not hidden. But it is the place a hostile reviewer would start.

6. What to Underwrite Next

Five items to watch over the next two reporting periods. None is a thesis breaker; together they would change the grade if they move the wrong way.

1. CFO / Net Income trajectory. FY25 came in at 0.84 — the lowest since FY22. If 1H FY26 prints under 0.7 alongside another DSO/inventory expansion, the grade moves from Watch to Elevated. Watch Note 54/55 of the FY26 consolidated accounts.

2. Other income disclosure. Other income is now 42% of operating profit. If the next AR does not give a clearer split between interest income, dividend income, and mark-to-market gains on the investment book, treat the line as lower-quality earnings (apply a haircut in DCF, not in EPS). Read Note 28 / Note 30 of the FY26 consolidated accounts (typically "Other Income" notes).

3. Receivables and inventory composition. Implied receivables jumped 57% in FY25 vs 14% revenue growth. The question to answer is how much is international distributor receivables (the Europe-distributor-liquidation comment on the Q4 FY25 call suggests this is a live issue) vs domestic dealer credit vs spares/accessories sales. A material concentration with a handful of distressed overseas distributors would be a red flag.

4. VECV equity-method line. Share of profit of JV ($82M) grew 56% YoY in FY25. The accounting is correct, but if the gap between Eicher's consolidated EPS and the VECV-inclusive group economics widens further, expect a sell-side push for a "look-through" view. There is no shenanigan here — just an interpretation issue investors should anticipate.

5. Executive compensation structure. compensation.json does not contain the figure detail; the proxy file is text-only. Read the Corporate Governance Report to confirm that the MD/CEO bonus pool is not weighted overwhelmingly to volume targets (which would push the company to ship into the dealer channel under pressure). The available evidence is neutral, not positive.

The forensic risk grade is Watch (22 / 100). The accounting is clean enough that this should not affect position sizing for an institutional position; it should affect the multiple you are willing to pay (mid-single-digit haircut versus an "all earnings are equal" view) and it should affect what you read first in the FY26 annual report (Note 54/55 on key ratios, the Other Income note, and the related-party transaction note for any VECV-side intercompany pricing surprises). If any one of CFO/NI, receivables growth, or other-income share moves materially in the wrong direction next year, revisit the grade.